Hemorragia alveolar difusa: causas y desenlaces en un instituto de tercer nivel

Reumatología Clínica 07/2010; DOI: 10.1016/j.reuma.2009.07.010
Source: OAI

ABSTRACT Objetivo Identificar las causas más frecuentes de hemorragia alveolar difusa (HAD) y conocer la evolución de los casos durante su hospitalización. Pacientes y método Revisión de expedientes con diagnóstico de HAD. Se clasificaron los diagnósticos de acuerdo con los criterios vigentes y se determinó la evolución. Resultados Se identificaron 17 casos de HAD, la principal causa fueron las vasculitis asociadas a ANCA (el 41% de los casos) seguida de las secundarias a drogas (el 18% de los casos). En un 35% no se logró identificar una etiología. Seis pacientes fallecieron (35%), el único factor asociado a mortalidad fue el sexo masculino (5/6 vs. 3/11; p=0,05). Conclusiones La causa más frecuente de hemorragia alveolar son las vasculitis asociadas a ANCA, la mortalidad de la HAD es del 35% y los hombres parecen tener peor pronóstico

Download full-text


Available from: Jorge Rojas-Serrano, Sep 03, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Based on a clinicopathologic study of 34 patients with biopsy-confirmed diffuse pulmonary hemorrhage (DPH), we present an approach to the differential diagnosis of DPH with attention to histologic features such as capillaritis and the importance of laboratory tests such as anticytoplasmic autoantibodies (ACPA). The following DPH syndromes were encountered: antibasement membrane antibody (ABMA) disease (four cases); idiopathic pulmonary hemorrhage (four cases); Wegener's granulomatosis (WG) (five cases); probable WG (six cases); systemic necrotizing vasculitis otherwise unclassified (three cases); systemic lupus erythematosus (two cases); rheumatoid arthritis (one case); seronegative juvenile rheumatoid arthritis (one case); IgA nephropathy (one case); idiopathic glomerulonephritis (two cases--one with and one without immune complexes); and unclassified pulmonary-renal syndromes (five cases). Capillaritis was found in lung biopsy samples from 30 of the 34 patients (88%) and included patients with every type of DPH syndrome. Serologic testing for ACPA was useful in the diagnosis of WG. Identification of ABMA in the serum, kidney, or lung was the defining feature for the diagnosis of ABMA-mediated disease. Subclassification of the cases could not be done solely on histologic grounds except for cases of WG that showed granulomatous inflammation, foci of necrosis, or vasculitis. Classification of the remaining cases required correlation with (a) clinical and laboratory data; (b) biopsy samples from other sites such as the kidney, nasal sinuses, or skin; and (c) results of immunofluorescence or electron microscopy of kidney or lung biopsy samples.
    American Journal of Surgical Pathology 01/1991; 14(12):1112-25. DOI:10.1097/00000478-199012000-00003 · 4.59 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Vasculitis, inflammation, and necrosis of blood vessels can involve any size or type of vessel in the pulmonary vasculature, including the capillaries, so-called capillaritis. Although pulmonary capillaritis is a histopathologic diagnosis that is not pathognomonic of a specific disorder, it usually signals the presence of an underlying systemic vasculitis or collagen vascular disease. Patients with pulmonary capillaritis usually present with bilateral infiltrates on chest radiographs and can be acutely ill with diffuse alveolar hemorrhage that may be life threatening. Therapy depends on diagnosis of the underlying disease that gave rise to the capillaritis. Since many of the disorders leading to capillaritis are treated by immunosuppression with corticosteroids and cyclophosphamide or azathioprine, infection must be excluded early in the course of therapy.
    Current opinion in pulmonary medicine 10/2000; 6(5):430-5. DOI:10.1097/00063198-200009000-00008 · 2.96 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Systemic Lupus International Collaborating Clinics, in preparation for revising the ACR classification criteria for systemic lupus erythematosus, reviewed the current classification criteria. These critical reviews, discussed at the Lund, Sweden, meeting in 2003, will be useful to the clinician and to the researcher. This paper reviews and critiques previous classification attempts.
    Lupus 02/2004; 13(11):829-37. DOI:10.1191/0961203304lu2019oa · 2.48 Impact Factor
Show more